Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Serina Therapeutics (SER) Interest Coverage Ratio (2021 - 2025)

Serina Therapeutics' Interest Coverage Ratio history spans 5 years, with the latest figure at 1065.33 for Q3 2025.

  • For Q3 2025, Interest Coverage Ratio fell 220.88% year-over-year to 1065.33; the TTM value through Sep 2025 reached 730.12, down 34361.21%, while the annual FY2024 figure was 32.41, 477.98% down from the prior year.
  • Interest Coverage Ratio for Q3 2025 was 1065.33 at Serina Therapeutics, down from 618.33 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 0.75 in Q4 2023 and bottomed at 1065.33 in Q3 2025.
  • The 5-year median for Interest Coverage Ratio is 11.19 (2023), against an average of 161.15.
  • The largest annual shift saw Interest Coverage Ratio skyrocketed 71.41% in 2022 before it plummeted 43508.05% in 2024.
  • A 5-year view of Interest Coverage Ratio shows it stood at 5.87 in 2021, then soared by 68.98% to 1.82 in 2022, then surged by 58.92% to 0.75 in 2023, then tumbled by 43508.05% to 326.41 in 2024, then crashed by 226.38% to 1065.33 in 2025.
  • Per Business Quant, the three most recent readings for SER's Interest Coverage Ratio are 1065.33 (Q3 2025), 618.33 (Q2 2025), and 326.41 (Q4 2024).